The GLP is committed to full transparency. Download and review our Annual Report.

Why we don’t test GMOs like pharmaceuticals

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

A very common question or criticism of GMOs is that they are not properly tested, particularly on humans. . . .

. . . .

. . .“[W]hy don’t we do clinical trials on GMOs the same way we do for drugs?” Drugs are designed to cause a change in the human body. . . Since drugs are altering something in humans, it’s important to know the side-effects. . . and whether or not they’re causing the anticipated effect . . . In contrast, GMOs are designed to be equivalent to their non-GE counterparts. . . GE crops which ARE designed to impact human health, such as vitamin-A enriched rice, should be tested in humans to determine if the desired outcome is achieved. . . .

Another reason why GMOs aren’t tested on humans is that there’s no plausible mechanism for harm.

. . . .

This isn’t a cop-out. If we’re looking for a harmful effect but don’t know what it is because we don’t have a reasonable mechanism whereby harm may occur, how can you design the experiment? What variables will you measure? . . . .

. . . [W]hat is exclusive or unique about GMOs that merits such rigorous testing, yet excludes other crop modification techniques?

Read full, original post: Why aren’t GMOs tested on humans?

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend